X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (48034) 48034
Publication (7670) 7670
Newsletter (1927) 1927
Book Review (400) 400
Book Chapter (252) 252
Dissertation (150) 150
Conference Proceeding (111) 111
Newspaper Article (84) 84
Magazine Article (56) 56
Book / eBook (17) 17
Web Resource (13) 13
Data Set (8) 8
Journal / eJournal (6) 6
Reference (6) 6
Government Document (5) 5
Trade Publication Article (4) 4
Paper (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23225) 23225
pseudomonas aeruginosa (20249) 20249
index medicus (20245) 20245
pseudomonas-aeruginosa (15838) 15838
microbiology (13972) 13972
animals (9494) 9494
pseudomonas aeruginosa - drug effects (8879) 8879
bacteria (8452) 8452
female (7715) 7715
male (7687) 7687
infectious diseases (7171) 7171
anti-bacterial agents - pharmacology (7141) 7141
microbial sensitivity tests (6241) 6241
pseudomonas aeruginosa - isolation & purification (6057) 6057
infections (5858) 5858
escherichia-coli (5442) 5442
antibiotics (5434) 5434
research (5304) 5304
pseudomonas infections - microbiology (5302) 5302
pharmacology & pharmacy (5209) 5209
infection (4816) 4816
cystic fibrosis (4667) 4667
adult (4487) 4487
mice (4486) 4486
immunology (4437) 4437
virulence (4223) 4223
pseudomonas aeruginosa - genetics (4162) 4162
analysis (3959) 3959
health aspects (3904) 3904
anti-bacterial agents - therapeutic use (3863) 3863
biofilms (3852) 3852
pseudomonas infections - drug therapy (3817) 3817
middle aged (3764) 3764
research article (3566) 3566
biochemistry & molecular biology (3522) 3522
resistance (3482) 3482
pathogens (2980) 2980
aged (2849) 2849
cystic-fibrosis (2718) 2718
bacterial proteins - genetics (2702) 2702
pseudomonas aeruginosa - pathogenicity (2701) 2701
pseudomonas aeruginosa - physiology (2641) 2641
pseudomonas aeruginosa - metabolism (2630) 2630
gram-negative bacteria (2624) 2624
respiratory system (2586) 2586
staphylococcus-aureus (2561) 2561
bacterial proteins - metabolism (2525) 2525
drug resistance in microorganisms (2503) 2503
adolescent (2418) 2418
proteins (2365) 2365
child (2361) 2361
biofilm (2326) 2326
drug resistance (2316) 2316
biotechnology & applied microbiology (2200) 2200
expression (2193) 2193
mutation (2122) 2122
cystic fibrosis - microbiology (2116) 2116
pseudomonas aeruginosa - immunology (2114) 2114
genes (2025) 2025
physiological aspects (2025) 2025
identification (2022) 2022
pseudomonas aeruginosa - growth & development (2007) 2007
medicine (1998) 1998
article (1982) 1982
molecular sequence data (1979) 1979
bacterial infections (1974) 1974
multidisciplinary sciences (1968) 1968
biochemical phenomena, metabolism, and nutrition (1956) 1956
staphylococcus aureus - drug effects (1929) 1929
pneumonia (1926) 1926
biofilms - growth & development (1917) 1917
drug resistance, bacterial (1900) 1900
in-vitro (1878) 1878
biofilms - drug effects (1876) 1876
genetic aspects (1875) 1875
antimicrobial agents (1867) 1867
risk factors (1851) 1851
staphylococcus aureus (1843) 1843
escherichia coli - drug effects (1825) 1825
gene expression (1815) 1815
anti-bacterial agents - administration & dosage (1743) 1743
pseudomonas aeruginosa - enzymology (1732) 1732
cystic fibrosis - complications (1712) 1712
epidemiology (1706) 1706
cross infection - microbiology (1701) 1701
life sciences (1684) 1684
escherichia coli (1632) 1632
antibacterial agents (1599) 1599
nosocomial infections (1595) 1595
antibiotic resistance (1594) 1594
inflammation (1590) 1590
disease models, animal (1579) 1579
antibiotic-resistance (1543) 1543
bacteriology (1535) 1535
drug resistance, microbial (1535) 1535
drug resistance, multiple, bacterial (1531) 1531
e coli (1524) 1524
gene expression regulation, bacterial (1519) 1519
quorum sensing (1511) 1511
mortality (1490) 1490
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (47254) 47254
Japanese (827) 827
French (719) 719
German (486) 486
Russian (467) 467
Spanish (365) 365
Chinese (219) 219
Polish (155) 155
Italian (129) 129
Persian (68) 68
Turkish (59) 59
Portuguese (49) 49
Korean (39) 39
Czech (38) 38
Romanian (33) 33
Dutch (25) 25
Hungarian (18) 18
Arabic (17) 17
Danish (14) 14
Croatian (10) 10
Swedish (10) 10
Ukrainian (10) 10
Serbian (8) 8
Slovak (8) 8
Norwegian (7) 7
Bulgarian (6) 6
Hebrew (4) 4
Afrikaans (3) 3
Lithuanian (2) 2
Slovenian (2) 2
Bosnian (1) 1
Icelandic (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 8/2008, Volume 321, Issue 5889, pp. 691 - 696
MyD88 is a key downstream adapter for most Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs). MyD88 deficiency in mice leads to susceptibility to... 
Receptors | Phenotypes | Transfection | Cytokines | HEK293 cells | Genes | Cell lines | Fibroblasts | Agonists | Reports | Children | MYD88-DEFICIENT MICE | HERPES-SIMPLEX-VIRUS | PROTECTIVE IMMUNITY | MYELOID DIFFERENTIATION FACTOR-88 | PSEUDOMONAS-AERUGINOSA | MULTIDISCIPLINARY SCIENCES | HUMORAL IMMUNITY | STAPHYLOCOCCUS-AUREUS | AERUGINOSA LUNG INFECTION | HOST RESPONSE | CUTTING EDGE | Humans | Child, Preschool | Male | Mutation, Missense | Bacterial Infections - genetics | Pneumococcal Infections - immunology | Bacterial Infections - immunology | Gene Deletion | Pneumococcal Infections - genetics | Female | Toll-Like Receptors - metabolism | Child | Staphylococcal Infections - genetics | Disease Susceptibility | Cytokines - metabolism | Signal Transduction | Staphylococcal Infections - immunology | Receptors, Interleukin-1 - immunology | Toll-Like Receptors - immunology | Myeloid Differentiation Factor 88 - genetics | Immunity, Innate | Pseudomonas Infections - genetics | Pseudomonas Infections - immunology | Receptors, Interleukin-1 - metabolism | Animals | Myeloid Differentiation Factor 88 - deficiency | Adolescent | Mice | Myeloid Differentiation Factor 88 - metabolism | Cell Line, Transformed | Genetic aspects | Bacterial infections | Pediatrics | Bacteria | Biomedical research | Genetic disorders | Immunology | Pneumococcal Infections | Life Sciences | Toll-Like Receptors | Bacterial Infections | Myeloid Differentiation Factor 88 | Bacteriology | Staphylococcal Infections | Microbiology and Parasitology | Pseudomonas Infections | Receptors, Interleukin-1
Journal Article
Journal of Infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 11/2014, Volume 210, Issue 9, pp. 1357 - 1366
Background. Limitations in treatment of biofilm-associated bacterial infections are often due to subpopulation of persistent bacteria (persisters) tolerant to... 
Biofilms | Antibiotics | Escherichia coli | Bacteria | Aminoglycosides | Pseudomonas aeruginosa | Infections | Basic amino acids | Staphylococcus aureus | aminoglycoside | persister | catheter-related infections | biofilm | proton motive force | DIAGNOSIS | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | TOLERANCE | SUSCEPTIBILITY | MICROBIOLOGY | IMMUNOLOGY | ANTIBIOTIC-LOCK THERAPY | GENTAMICIN | PSEUDOMONAS-AERUGINOSA | L-ARGININE | GROWTH | Escherichia coli Infections - prevention & control | Central Venous Catheters - microbiology | Escherichia coli - drug effects | Gentamicins - administration & dosage | Catheter-Related Infections - prevention & control | Pseudomonas Infections - prevention & control | Arginine - administration & dosage | Gentamicins - pharmacology | Drug Therapy, Combination | Biofilms - drug effects | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Pseudomonas Infections - drug therapy | Rats | Central Venous Catheters - adverse effects | Pseudomonas aeruginosa - drug effects | Catheter-Related Infections - drug therapy | Drug Synergism | Animals | Arginine - pharmacology | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | In Vitro Techniques | Staphylococcus aureus - drug effects | Hydrogen-Ion Concentration | Health aspects | Research | Index Medicus | Abridged Index Medicus | Biofilms/drug effects | Gentamicins/administration & dosage | Anti-Bacterial Agents/pharmacology | Staphylococcal Infections/drug therapy | Arginine/administration & dosage | Life Sciences | Escherichia coli Infections/drug therapy | Staphylococcus aureus/drug effects | Gentamicins/pharmacology | Catheter-Related Infections/prevention & control | Pseudomonas aeruginosa/drug effects | Staphylococcal Infections/prevention & control | Catheter-Related Infections/drug therapy | Central Venous Catheters/microbiology | Escherichia coli/drug effects | Bacteriology | Microbiology and Parasitology | Central Venous Catheters/adverse effects | Arginine/pharmacology | Pseudomonas Infections/prevention & control | Escherichia coli Infections/prevention & control | Pseudomonas Infections/drug therapy
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 2012, Volume 40, Issue 5, pp. 396 - 407
The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in... 
Infectious Disease | Infection Control | Nosocomial infection | Ventilator-associated pneumonia | Low-income countries | Bloodstream infection | Developing countries | Central line-associated bloodstream infection | Limited-resources countries | Health care-associated infection | Urinary tract infection | Catheter-associated urinary tract infection | Network | Antibiotic resistance | Hospital infection | Device-associated infection | MORTALITY | INTENSIVE-CARE UNITS | CONTROL PROGRAM | RATES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PERFORMANCE FEEDBACK | SAFETY NETWORK | INFECTIOUS DISEASES | LENGTH-OF-STAY | ARGENTINEAN HOSPITALS | BLOOD-STREAM INFECTIONS | Africa - epidemiology | Prevalence | Prospective Studies | Humans | Middle Aged | Cross Infection - mortality | Child, Preschool | Infant | Male | Young Adult | Aged, 80 and over | Bacteria - classification | Adult | Female | Child | Infant, Newborn | Cross Infection - epidemiology | Latin America - epidemiology | Intensive Care Units | Europe - epidemiology | International Cooperation | Asia - epidemiology | Bacteria - isolation & purification | Adolescent | Bacterial Infections - epidemiology | Aged | Bacterial Infections - mortality | Consortia | Medical colleges | Pneumonia | Hotels and motels | Bacterial pneumonia | Staphylococcus aureus infections | Urinary tract infections | Health aspects | Antibacterial agents | Public health | Infection control
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 661 - 673
Journal Article
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 9/2018, Volume 37, Issue 9, pp. 1627 - 1636
The proportion of antimicrobial resistance (AMR) among the ESKAPE and Escherichia coli (ESKAPEEc) pathogens causing bloodstream infection (BSI) increased... 
Medical Microbiology | Biomedicine | Targeted therapy | Escherichia coli | Bloodstream infections | Internal Medicine | ESKAPE | Antimicrobial resistance | MORTALITY | INFECTIOUS DISEASES | MULTICENTER | MICROBIOLOGY | THERAPY | PREDICTORS | DISSEMINATION | ENTEROBACTERIACEAE | PATHOGENS | Escherichia coli - drug effects | Humans | Escherichia coli Infections - blood | Molecular Targeted Therapy | Incidence | Bacteremia - microbiology | Hospitals, Teaching - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | beta-Lactamases - drug effects | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Bacterial Proteins - drug effects | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Beta lactamases | Health aspects | Public health | Klebsiella | Health care | Pathogens | Communities | Carbapenemase | Antimicrobial agents | Infections | Drug resistance | Antiinfectives and antibacterials | Methicillin | E coli | Pseudomonas aeruginosa | Bacteria | Meropenem | Trends | Ciprofloxacin | Active control | Emergency medical services | Ceftazidime
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, p. e56846
Journal Article